Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel circ_0000654/miR-375/E2F3 ceRNA network in esophageal squamous cell carcinoma. | Thorac Cancer | 2022 | 35790503 | PubTator, text mining | PubMed |
| Applications and Achievements of Single-Cell Sequencing in Gastrointestinal Cancer. | Front Oncol | 2022 | 35785171 | PubTator, text mining | PubMed |
| Downregulation of hsa_circ_0000885 suppressed osteosarcoma metastasis and progression via regulating E2F3 expression and sponging miR-16-5p. | Regen Ther | 2022 | 35785045 | PubTator, text mining | PubMed |
| Urinary extracellular vesicle as a potential biomarker of exercise-induced fatigue in young adult males. | Eur J Appl Physiol | 2022 | 35781843 | PubTator, text mining | PubMed |
| The Novel Regulatory Role of the lncRNA-miRNA-mRNA Axis in Chronic Inflammatory Airway Diseases. | Front Mol Biosci | 2022 | 35769905 | PubTator, text mining | PubMed |
| Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts. | BMC Pediatr | 2022 | 35764946 | PubTator, text mining | PubMed |
| Human miRNAs to Identify Potential Regions of SARS-CoV-2. | ACS Omega | 2022 | 35755383 | PubTator, text mining | PubMed |
| The Potential Diagnostic Value of Immune-Related Genes in Interstitial Fibrosis and Tubular Atrophy after Kidney Transplantation. | J Immunol Res | 2022 | 35755170 | PubTator, text mining | PubMed |
| Guilt by association: EcDNA as a mobile transactivator in cancer. | Trends Cancer | 2022 | 35753910 | PubTator, text mining | PubMed |
| Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs. | Molecules | 2022 | 35744941 | PubTator, text mining | PubMed |
| ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance. | Int J Mol Sci | 2022 | 35743145 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities. | Biomedicines | 2022 | 35740349 | PubTator, text mining | PubMed |
| Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study. | Biomedicines | 2022 | 35740344 | PubTator, text mining | PubMed |
| Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer. | Front Pharmacol | 2022 | 35721151 | PubTator, text mining | PubMed |
| Long Noncoding RNA LINC00467: Role in Various Human Cancers. | Front Genet | 2022 | 35719391 | PubTator, text mining | PubMed |
| Integrative Analysis Identifies Cell-Type-Specific Genes Within Tumor Microenvironment as Prognostic Indicators in Hepatocellular Carcinoma. | Front Oncol | 2022 | 35707353 | PubTator, text mining | PubMed |
| Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer. | Transl Cancer Res | 2022 | 35706796 | PubTator, text mining | PubMed |
| Exosomal circRNA FNDC3B promotes the progression of esophageal squamous cell carcinoma by sponging miR-490-5p and regulating thioredoxin reductase 1 expression. | Bioengineered | 2022 | 35703190 | PubTator, text mining | PubMed |
| Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. | J Nanobiotechnology | 2022 | 35701788 | PubTator, text mining | PubMed |
| miR-214 Modulates the Growth and Migration of Oral Cancer before and after Chemotherapy through Mediating ULK1. | J Immunol Res | 2022 | 35692501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=32